You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 12, December 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury

H. P. Redmond, J. H. Wang and D. Bouchier-Hayes
Royal College of Surgeons in Ireland, Department of Surgery, Beaumont Hospital, Dublin, Ireland. surgres@iol.ie

OBJECTIVE: To evaluate the potential role of the semi-amino acid taurine in the prevention of hepatocyte (HC) apoptosis and necrosis mediated by nitric oxide (NO) and reactive oxygen intermediates. DESIGN: Isolated rat HCs were cultured with lipopolysaccharide (LPS), antioxidants, taurine, and sodium nitroprusside to examine the effect of these agents on HC injury. RESULTS: Lipopolysaccharide, in the presence of antioxidants, led to HC apoptosis, while LPS alone failed to induce HC apoptosis. Taurine significantly attenuated LPS plus antioxidant-mediated HC apoptosis, and this correlated with taurine-mediated NO inhibition. Taurine also significantly reduced LPS-mediated hepatocellular enzyme release and HC necrosis, and this correlated with HC free radical and peroxynitrite inhibition. However, taurine did not prevent sodium nitroprusside-mediated HC apoptosis and necrosis. CONCLUSIONS: Taurine attenuates HC apoptosis and necrosis through inhibition of both NO and reactive oxygen intermediate. While taurine acts directly as an antioxidant, its effects on NO may occur at the messenger RNA level. Our findings indicate a potential prophylactic and therapeutic role for this amino acid during systemic inflammatory response syndrome.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Thromboxane in Producing Hepatic Injury During Hepatic Stress
Yokoyama et al.
Arch Surg 2005;140:801-807.
ABSTRACT | FULL TEXT  

The Effects of Taurolidine, a Novel Antineoplastic Agent, on Human Malignant Mesothelioma
Nici et al.
Clin. Cancer Res. 2004;10:7655-7661.
ABSTRACT | FULL TEXT  

Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge
Nadler et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2001;281:G173-G181.
ABSTRACT | FULL TEXT  

Role of taurine in preventing acetaminophen-induced hepatic injury in the rat
Waters et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2001;280:G1274-G1279.
ABSTRACT | FULL TEXT  

The Relationship between Plasma Taurine and Other Amino Acid Levels in Human Sepsis
Chiarla et al.
J. Nutr. 2000;130:2222-2227.
ABSTRACT | FULL TEXT  

Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis
di Wu et al.
Am. J. Physiol. Cell Physiol. 1999;277:C1229-C1238.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.